BioCentury
ARTICLE | Politics & Policy

Michigan to begin talks with drug manufacturers for value-based deals

November 14, 2018 11:55 PM UTC

With a stamp of approval from CMS on Wednesday, Michigan joins Oklahoma as one of the only two states with the agency's OK to negotiate Medicaid outcomes-based pricing agreements with drug manufacturers.

"Michigan’s waiver will empower the state to demand results from drug manufacturers in exchange for paying for medicines," CMS Administrator Seema Verma said in a speech at the Biopharma Congress on Wednesday...